Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS
previous post
Elon Musk’s politics are hurting Tesla, 85% say in investor survey
next post
FDA chief counsel who defended abortion pill access under Biden resigns two days into job

Related Posts

GOP senator demands FBI probe Biden-era vetting process...

June 2, 2025

Trump’s House allies unveil bill ‘hand in hand’...

February 11, 2025

Panama eliminates charge fees for U.S. government vessels...

February 6, 2025

MIKE DAVIS: The real reason Big Tech is...

February 6, 2025

Trump, Harris trade barbs on crime during first...

September 11, 2024

Trump hails cooperative effort at anti-revenge porn bill...

May 19, 2025

Hegseth signs ‘No More Walking on Eggshells’ policy,...

April 25, 2025

Trump previously predicted Biden would pardon son Hunter

December 2, 2024

‘Can’t wait till the last minute’: NC congressman...

October 12, 2024

Republicans look to stop China’s ‘backdoor’ tariff dodging...

May 22, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Trump secures record-shattering $1.4B for political war chest; will be ‘dominant force’ for GOP in midterms

      June 27, 2025
    • Trump says ‘big, beautiful’ bill ‘must’ meet deadline as some Republicans waver

      June 27, 2025
    • Barrett eviscerates Jackson, Sotomayor takes on a ‘complicit’ court in contentious final opinions

      June 27, 2025
    • Trump would strike Iran ‘without question’ if it restarts nuclear weapons program

      June 27, 2025
    • Florida man indicted for ’86’ posts allegedly threatening to kill Alina Habba

      June 27, 2025
    • Top House Republicans send stern warning to Senate GOP as Trump’s ‘big, beautiful bill’ risks delay

      June 27, 2025

    Categories

    • Business (1,283)
    • Politics (6,170)
    • Stocks (904)
    • World News (460)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved